LOX is another factor produced by MAFs to enhance metastatic tumor cells’ proliferative level, which can reprogram glucose metabolism of metastatic tumor cells via the protein kinase B (AKT)-p70S6K/ hypoxia inducible factor 1 subunit alpha (HIF1α) pathway [57]. This evidence concerns the gene AKT1 and neoplasm.